Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib

BACKGROUND: Pain is a core domain of psoriatic arthritis (PsA). This post hoc analysis evaluated time to pain improvement and the impact of baseline pain severity on pain response in patients with PsA receiving tofacitinib. METHODS: Data from two trials (NCT01877668; NCT01882439) in patients receivi...

Descripción completa

Detalles Bibliográficos
Autores principales: de Vlam, Kurt, Ogdie, Alexis, Bushmakin, Andrew G, Cappelleri, Joseph C, Fleischmann, Roy, Taylor, Peter C, Azevedo, Valderilio, Fallon, Lara, Woolcott, John, Mease, Philip J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258668/
https://www.ncbi.nlm.nih.gov/pubmed/34226183
http://dx.doi.org/10.1136/rmdopen-2021-001609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258668/
https://www.ncbi.nlm.nih.gov/pubmed/34226183
http://dx.doi.org/10.1136/rmdopen-2021-001609

Ejemplares similares